AAAAAA

   
Results: 1-17 |
Results: 17
Symptom profiles in children with ADHD: Effects of comorbidity and gender
Authors: Newcorn, JH Halperin, JM Jensen, PS Abikoff, HB Arnold, LE Cantwell, DP Conners, CK Elliott, GR Epstein, JN Greenhill, LL Hechtman, L Hinshaw, SP Hoza, B Kraemer, HC Pelham, WE Severe, JB Swanson, JM Wells, KC Wigal, T Vitiello, B
Citation: Jh. Newcorn et al., Symptom profiles in children with ADHD: Effects of comorbidity and gender, J AM A CHIL, 40(2), 2001, pp. 137-146
ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups
Authors: Jensen, PS Hinshaw, SP Kraemer, HC Lenora, N Newcorn, JH Abikoff, HB March, JS Arnold, LE Cantwell, DP Conners, CK Elliott, GR Greenhill, LL Hechtman, L Hoza, B Pelham, WE Severe, JB Swanson, JM Wells, KC Wigal, T Vitiello, B
Citation: Ps. Jensen et al., ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups, J AM A CHIL, 40(2), 2001, pp. 147-158
Multimodal treatment of ADHD in the MTA: An alternative outcome analysis
Authors: Conners, CK Epstein, JN March, JS Angold, A Wells, KC Klaric, J Swanson, JM Arnold, LE Abikoff, HB Elliott, GR Greenhill, LL Hechtman, L Hinshaw, SP Hoza, B Jensen, PS Kraemer, HC Newcorn, JH Pelham, WE Severe, JB Vitiello, B Wigal, T
Citation: Ck. Conners et al., Multimodal treatment of ADHD in the MTA: An alternative outcome analysis, J AM A CHIL, 40(2), 2001, pp. 159-167
Clinical relevance of the primary findings of the MTA: Success rates basedon severity of ADHD and ODD symptoms at the end of treatment
Authors: Swanson, JM Kraemer, HC Hinshaw, SP Arnold, LE Conners, CK Abikoff, HB Clevenger, W Davies, M Elliott, GR Greenhill, LL Hechtman, L Hoza, B Jensen, PS March, JS Newcorn, JH Owens, EB Pelham, WE Schiller, E Severe, JB Simpson, S Vitiello, B Wells, K Wigal, T Wu, M
Citation: Jm. Swanson et al., Clinical relevance of the primary findings of the MTA: Success rates basedon severity of ADHD and ODD symptoms at the end of treatment, J AM A CHIL, 40(2), 2001, pp. 168-179
Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial
Authors: Greenhill, LL Swanson, JM Vitiello, B Davies, M Clevenger, W Wu, M Arnold, LE Abikoff, HB Bukstein, OG Conners, CK Elliott, GR Hechtman, L Hinshaw, SP Hoza, B Jensen, PS Kraemer, HC March, JS Newcorn, JH Severe, JB Wells, K Wigal, T
Citation: Ll. Greenhill et al., Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial, J AM A CHIL, 40(2), 2001, pp. 180-187
Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA
Authors: Vitiello, B Severe, JB Greenhill, LL Arnold, LE Abikoff, HB Bukstein, OG Elliott, GR Hechtman, L Jensen, PS Hinshaw, SP March, JS Newcorn, JH Swanson, JM Cantwell, DP
Citation: B. Vitiello et al., Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA, J AM A CHIL, 40(2), 2001, pp. 188-196
A prevalidation study on in vitro tests for acute skin irritation: resultsand evaluation by the Management Team
Authors: Fentem, JH Briggs, D Chesne, C Elliott, GR Harbell, JW Heylings, JR Portes, P Roguet, R van de Sandt, JJM Botham, PA
Citation: Jh. Fentem et al., A prevalidation study on in vitro tests for acute skin irritation: resultsand evaluation by the Management Team, TOX VITRO, 15(1), 2001, pp. 57-93
Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: A single-blinded, open-label pilot study
Authors: Lighdale, JR Hayer, C Duer, A Lind-White, C Jenkins, S Siegel, B Elliott, GR Heyman, MB
Citation: Jr. Lighdale et al., Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: A single-blinded, open-label pilot study, PEDIATRICS, 108(5), 2001, pp. NIL_83-NIL_87
An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder
Authors: Stein, MT Shafer, MA Elliott, GR Levine, S
Citation: Mt. Stein et al., An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder, PEDIATRICS, 107(4), 2001, pp. 974-978
An automated method for the quantification of immunostained human Langerhans cells
Authors: Jacobs, JJL Lehe, C Cammans, KDA Yoneda, K Das, PK Elliott, GR
Citation: Jjl. Jacobs et al., An automated method for the quantification of immunostained human Langerhans cells, J IMMUNOL M, 247(1-2), 2001, pp. 73-82
Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur
Authors: van de Sandt, JJM Meuling, WJA Elliott, GR Cnubben, NHP Hakkert, BC
Citation: Jjm. Van De Sandt et al., Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur, TOXICOL SCI, 58(1), 2000, pp. 15-22
An automated method for registering and quantifying scratching activity inmice - Use for drug evaluation
Authors: Elliott, GR Vanwersch, RAP Bruijnzeel, PLB
Citation: Gr. Elliott et al., An automated method for registering and quantifying scratching activity inmice - Use for drug evaluation, J PHARM TOX, 44(3), 2000, pp. 453-459
Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm)
Authors: Gijbels, MJJ Elliott, GR HogenEsch, H Zurcher, C van den Hoven, A Bruijnzeel, PLB
Citation: Mjj. Gijbels et al., Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm), EXP DERMATO, 9(5), 2000, pp. 351-358
Methyl green-pyronine staining of porcine organotypic skin explant cultures: An alternative model for screening for skin irritants
Authors: Jacobs, JJL Lehe, C Cammans, KDA Das, PK Elliott, GR
Citation: Jjl. Jacobs et al., Methyl green-pyronine staining of porcine organotypic skin explant cultures: An alternative model for screening for skin irritants, ATLA-ALT L, 28(2), 2000, pp. 279-292
An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder
Authors: Stein, MT Shafer, MA Elliott, GR Levine, S
Citation: Mt. Stein et al., An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder, J DEV BEH P, 20(2), 1999, pp. 106-110
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder
Authors: Jensen, PS Arnold, LE Richters, JE Severe, JB Vereen, D Vitiello, B Schiller, E Hinshaw, SP Elliott, GR Conners, CK Wells, KC March, J Swanson, J Wigal, T Cantwell, DP Abikoff, HB Hechtman, L Greenhill, LL Newcorn, JH Pelham, WE Hoza, B Kraemer, HC
Citation: Ps. Jensen et al., A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder, ARCH G PSYC, 56(12), 1999, pp. 1073-1086
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder - The multimodal treatment study of children with attention-deficit/hyperactivity disorder
Authors: Jensen, PS Arnold, LE Richters, JE Severe, JB Vereen, D Vitiello, B Schiller, E Hinshaw, SP Elliott, GR Conners, CK Wells, KC March, J Swanson, J Wigal, T Cantwell, DP Abikoff, HB Hechtman, L Greenhill, LL Newcorn, JH Pelham, WE Hoza, B Kraemer, HC
Citation: Ps. Jensen et al., Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder - The multimodal treatment study of children with attention-deficit/hyperactivity disorder, ARCH G PSYC, 56(12), 1999, pp. 1088-1096
Risultati: 1-17 |